MS Stock Analysis: Morgan Stanley | NYSE
Capital Markets | NYSE, USA | Market Cap: 343.278m USD | 12M Return: 57.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.34B
EPS Trend: 98.7%
Qual. Beats: 10
Rev. Trend: 99.2%
Qual. Beats: 5
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Morgan Stanley (NYSE: MS) is a global financial holding company founded in 1924 and headquartered in New York. It operates through three core segments: Institutional Securities, Wealth Management, and Investment Management, serving corporations, governments, financial institutions, and individuals across the Americas, Asia, Europe, the Middle East, and Africa.
The Institutional Securities segment generates investment-banking fees from underwriting debt and equity offerings, mergers and acquisitions advisory, restructurings, and project finance, and also runs market-making, prime brokerage, and financing activities in equities and fixed income. The Wealth Management segment provides advisor-led and self-directed brokerage, investment advisory, custody, cash management, lending products (including securities-based and residential real estate loans), and retirement plan services, giving the firm a sizable base of recurring fee-based revenue. The Investment Management segment offers equity, fixed income, alternatives, and liquidity/overlay services to institutional and individual clients such as pension plans, foundations, endowments, sovereign wealth funds, and insurance companies.
Within the Financials sector, Morgan Stanley is classified in the Investment Banking & Brokerage sub-industry, a group whose earnings tend to be split between cyclical capital-markets activity and more stable, fee-driven wealth and asset management businesses. The firms mix of advisory, trading, lending, and long-term asset and wealth management is intended to balance revenue across economic cycles, with wealth and investment management typically providing a larger share of steady income and institutional securities contributing more market-sensitive results.
- Wealth Management fee revenues grow on expanding advisor-led AUM
- Investment banking advisory revenue rises on M&A recovery
- Net interest income moves with Fed rate cuts
| Net Income: 20.2b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 2.27 > 1.0 |
| NWC/Revenue: 323.5% < 20% (prev -582.0%; Δ 905.5% < -1%) |
| CFO/TA -0.00 > 3% & CFO -1.01b > Net Income 20.2b |
| Net Debt (-266b) to EBITDA (30.9b): -8.60 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.59b) vs 12m ago -0.44% < -2% |
| Gross Margin: 59.72% > 18% (prev 56.26%; Δ 3.46% > 0.5%) |
| Asset Turnover: 8.78% > 50% (prev 8.34%; Δ 0.45% > 0%) |
| Interest Coverage Ratio: 0.52 > 6 (EBIT TTM 26.2b / Interest Expense TTM 50.8b) |
| A: 0.26 (Total Current Assets 1076b - Total Current Liabilities 666b) / Total Assets 1581b |
| B: 0.08 (Retained Earnings 119b / Total Assets 1581b) |
| C: 0.02 (EBIT TTM 26.2b / Avg Total Assets 1441b) |
| D: 0.08 (Book Value of Equity 114b / Total Liabilities 1466b) |
| Altman-Z'' = 2.15 = BBB |
| DSRI: 1.23 (Receivables 133b/92.2b, Revenue 127b/108b) |
| GMI: 0.94 (GM 56.26% / 59.72%) |
| AQI: 0.37 (AQ_t 0.32 / AQ_t-1 0.86) |
| SGI: 1.17 (Revenue 127b / 108b) |
| TATA: 0.01 (NI 20.2b - CFO -1.01b) / TA 1581b) |
| Beneish M = -3.14 (Cap -4..+1) = AA |
As of July 20, 2026, the stock is trading at USD 215.50 with a total of 6,727,757 shares traded. Over the past week, the price has changed by -3.05%, over one month by -5.10%, over three months by +13.61% and over the past year by +57.12%.
Current recommended Stop Loss: 206.80 (which is 4% or 1.3 ATR below the current price).
Morgan Stanley has received a consensus analysts rating of 3.68. Therefore, it is recommended to hold MS.
- StrongBuy: 8
- Buy: 2
- Hold: 14
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 224.3 | 4.1% |
P/E Trailing = 17.6247
P/E Forward = 19.2678
P/S = 4.6913
P/B = 3.4369
P/EG = 2.713
Revenue TTM = 127b USD
EBIT TTM = 26.2b USD
EBITDA TTM = 30.9b USD
Long Term Debt = 371b USD (from longTermDebt, last quarter)
Short Term Debt = 22.7b USD (from shortTermDebt, last quarter)
Debt = 394b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -266b USD (calculated: Debt 394b - CCE 660b)
Enterprise Value = 77.8b USD (343b + Debt 394b - CCE 660b)
Interest Coverage Ratio = 0.52 (Ebit TTM 26.2b / Interest Expense TTM 50.8b)
EV/FCF = -73.93x (Enterprise Value 77.8b / FCF TTM -1.05b)
FCF Yield = -1.35% (FCF TTM -1.05b / Enterprise Value 77.8b)
FCF Margin = -0.83% (FCF TTM -1.05b / Revenue TTM 127b)
Net Margin = 15.99% (Net Income TTM 20.2b / Revenue TTM 127b)
Gross Margin = 59.72% ((Revenue TTM 127b - Cost of Revenue TTM 51.0b) / Revenue TTM)
Gross Margin QoQ = 61.65% (prev 61.79%)
Tobins Q-Ratio = 0.05 (Enterprise Value 77.8b / Total Assets 1581b)
Interest Expense / Debt = 12.87% (Interest Expense 50.8b / Debt 394b)
Taxrate = 22.09% (5.78b / 26.1b)
NOPAT = 20.4b (EBIT 26.2b * (1 - 22.09%))
Current Ratio = 1.61 (Total Current Assets 1076b / Total Current Liabilities 666b)
Debt / Equity = 3.45 (Debt 394b / totalStockholderEquity, last quarter 114b)
Debt / EBITDA = -8.60 (Net Debt -266b / EBITDA 30.9b)
Debt / FCF = 252.4 (negative FCF - burning cash) (Net Debt -266b / FCF TTM -1.05b)
Total Stockholder Equity = 111b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.40% (Net Income 20.2b / Total Assets 1581b)
RoE = 18.22% (Net Income TTM 20.2b / Total Stockholder Equity 111b)
RoCE = 5.44% (EBIT 26.2b / Capital Employed (Equity 111b + L.T.Debt 371b))
RoIC = 2.19% (NOPAT 20.4b / Invested Capital 931b)
WACC = 10.67% (E(343b)/V(738b) * Re(11.41%) + D(394b)/V(738b) * Rd(12.87%) * (1-Tc(0.22)))
Discount Rate = 11.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.92 | Cagr: -0.64%
[DCF] Fair Price = unknown (Cash Flow -1.05b)
EPS Correlation: 98.75 | EPS CAGR: 33.94% | SUE: 2.89 | # QB: 10
Revenue Correlation: 99.19 | Revenue CAGR: 14.21% | SUE: 1.02 | # QB: 5
EPS current Quarter (2026-09-30): EPS=3.11 | Chg30d=+7.18% | Revisions=+44% | Analysts=12
EPS current Year (2026-12-31): EPS=12.98 | Chg30d=+9.56% | Revisions=+67% | GrowthEPS=+27.2% | GrowthRev=+14.0%
EPS next Year (2027-12-31): EPS=13.32 | Chg30d=+4.90% | Revisions=+62% | GrowthEPS=+2.6% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +75% (up=16, down=1)